BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1983280)

  • 21. Partial deletion of the αC-domain in the Fibrinogen Perth variant is associated with thrombosis, increased clot strength and delayed fibrinolysis.
    Westbury SK; Duval C; Philippou H; Brown R; Lee KR; Murden SL; Phillips E; Reilly-Stitt C; Whalley D; Ariëns RA; Mumford AD
    Thromb Haemost; 2013 Dec; 110(6):1135-44. PubMed ID: 24048413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antifibrinolytics gynaecology and obstetrics.
    Koutský J; Hladovec J
    Acta Univ Carol Med (Praha); 1975; 21(5-6):235-386. PubMed ID: 132853
    [No Abstract]   [Full Text] [Related]  

  • 23. The influence of the haemodialysis procedure on platelets, coagulation and fibrinolysis.
    Sabovic M; Salobir B; Preloznik Zupan I; Bratina P; Bojec V; Buturovic Ponikvar J
    Pathophysiol Haemost Thromb; 2005; 34(6):274-8. PubMed ID: 16772739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Significance of thrombogenesis in the pathogenesis of arteriosclerosis (literature review)].
    Zaĭtsev VF; Ananchenko VG
    Kardiologiia; 1967 Jan; 7(1):83-7. PubMed ID: 4882302
    [No Abstract]   [Full Text] [Related]  

  • 25. [Use of chromogenic substrates for the diagnosis of blood coagulation and fibrinolytic disorders].
    Bokarev IN; Butorov VN; Loginov LE
    Ter Arkh; 1981; 53(2):118-24. PubMed ID: 6452714
    [No Abstract]   [Full Text] [Related]  

  • 26. [Thrombophilia and intravascular coagulation: new physiopathologic and therapeutic trends].
    De Nicola P
    G Gerontol; 1968 Oct; 16(10):1177-84. PubMed ID: 5734772
    [No Abstract]   [Full Text] [Related]  

  • 27. Dysfunctional coagulation and fibrinolysis systems due to adenomyosis is a possible cause of thrombosis and menorrhagia.
    Yamanaka A; Kimura F; Yoshida T; Kita N; Takahashi K; Kushima R; Murakmai T
    Eur J Obstet Gynecol Reprod Biol; 2016 Sep; 204():99-103. PubMed ID: 27543913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Disorders of blood coagulation homeostasis in the pathogenesis of intravascular blood coagulation and thrombus formation].
    Gritsiuk AI
    Vrach Delo; 1984 Oct; (10):56-60. PubMed ID: 6516310
    [No Abstract]   [Full Text] [Related]  

  • 29. Experimental models of defibrination states.
    Lipiński B
    Pol Med J; 1971; 10(3):619-26. PubMed ID: 4256509
    [No Abstract]   [Full Text] [Related]  

  • 30. Editorial: Predisposition to thrombosis.
    Lancet; 1974 Dec; 2(7894):1430-1. PubMed ID: 4140336
    [No Abstract]   [Full Text] [Related]  

  • 31. [Thrombosis and hypercoagulable states].
    Páramo JA; Cuesta B; Fernández J; Alfaro MJ; Paloma MJ; Rocha E
    Rev Med Univ Navarra; 1987; 31(4):233-7. PubMed ID: 3327132
    [No Abstract]   [Full Text] [Related]  

  • 32. The problem of intravascular fibrinolytic reaction.
    Fletcher AP
    Thromb Diath Haemorrh Suppl; 1967; 26():343-50. PubMed ID: 6064865
    [No Abstract]   [Full Text] [Related]  

  • 33. Fibrinolysis.
    Sherry S
    Annu Rev Med; 1968; 19():247-68. PubMed ID: 4172727
    [No Abstract]   [Full Text] [Related]  

  • 34. An increased tendency in fibrinogen activity and its association with a hypo-fibrinolytic state in early stages after injury in patients without acute traumatic coagulopathy (ATC).
    He S; Blombäck M; Boström F; Wallen H; Svensson J; Östlund A
    J Thromb Thrombolysis; 2018 May; 45(4):477-485. PubMed ID: 29564685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The investigation of a heart valve patient with suspected hypercoagulability.
    Gough SC; Prentice CR
    J Heart Valve Dis; 1993 Jan; 2(1):7-17. PubMed ID: 8269113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in blood coagulation and fibrinolysis in the normal puerperium.
    Dahlman T; Hellgren M; Blombäck M
    Gynecol Obstet Invest; 1985; 20(1):37-44. PubMed ID: 3930349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Characteristics of the indicators of the blood coagulation and fibrinolysis systems in the pre-clinical stage of ischemic heart disease].
    Andreenko GV; Panchenko VM; Lisina AN; Liutova LV
    Kardiologiia; 1978 Oct; 18(10):57-60. PubMed ID: 713256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An in vitro study of the effects of t-PA and tranexamic acid on whole blood coagulation and fibrinolysis.
    Godier A; Parmar K; Manandhar K; Hunt BJ
    J Clin Pathol; 2017 Feb; 70(2):154-161. PubMed ID: 27445340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coagulolysis: mechanism of formation and lysis of dilute whole blood clots and application of this assay into study of certain hypercoagulable states.
    Taylor FB; Nilsson UR; Creech RH; Carroll ET; Beisswenger JG
    Ser Haematol; 1973; 6(4):528-48. PubMed ID: 4277409
    [No Abstract]   [Full Text] [Related]  

  • 40. Coagulation disorders.
    Bonnar J
    J Clin Pathol Suppl (R Coll Pathol); 1976; 10():35-41. PubMed ID: 1067268
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.